Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism USP7 inhibitors(ubiquitin specific peptidase 7 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Lymphoblastic Leukemia | Preclinical | CN | 19 Jul 2024 |